​Post Authorization Safety Studies with Nancy Dreyer


Global approaches to post-approval safety are changing rapidly around the world. If you are bringing a new drug or device to market in Europe, you will want to know how companies are satisfying their post-authorization safety requirements. New pharmacovigilance regulations were implemented in Europe in 2012. IQVIA looked at what happened in the 3 years after implementation. Learn how IQVIA can help you navigate the challenges and the opportunities of this new era in Post-Authorization Safety Studies (PASS). TRT: 3:30